The role of T-cells and Th 1 immunity in cholesterol gallstones
T 细胞和 Th 1 免疫在胆固醇胆结石中的作用
基本信息
- 批准号:7384675
- 负责人:
- 金额:$ 13.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-22 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:B-LymphocytesBile fluidBiliaryBiliary calculiBiological ModelsCD4 Positive T LymphocytesCD8B1 geneCalculiCell SeparationCellsCholecystitisCholelithiasisCholesterolComplexContractsCytotoxic T-LymphocytesDataDiagnosisDiseaseEnvironmental Risk FactorEragrostisEventFluorescenceGallbladderGeneticGoalsHepaticHumanImmuneImmune responseImmunityIn VitroInbred C57BL MiceInflammationKineticsLeucocytic infiltrateLipidsMediatingMicroscopicModelingMolecularMusPathogenesisPhenotypePrevalenceProductionRateResearch PersonnelRoleSeriesT-LymphocyteT-Lymphocyte SubsetsTestingWild Type Mousebasecell injurycytokinein vivoinsightlipid metabolismloss of functionpreventprogramstreatment effect
项目摘要
DESCRIPTION (provided by applicant):
Cholesterol gallstones are a common costly disease with a complex incompletely understood pathogensesis [sic] involving genetic and environmental contributions. In general, these stones form in the gallbladder when bile is supersaturated with cholesterol. However, supersaturated bile is not sufficient to produce cholesterol gallstones. The environmental factors which contribute to cholesterol gallstone formation are largely unknown and recent studies indicate that, in humans, unique environmental factors demonstrate a greater than 50% contribution to gallstone formation. Recently we demonstrated that the adaptive immune response contributes greatly to cholesterol gallstone formation. We hypothesize that adaptive immune stimulation is one of the environmental factors contributing to cholesterol gallstones in humans. Based upon the data generated to date a likely biological model for this formation is T-cell mediated damage to the gallbladder wall leading to a progressive loss of function of the gallbladder. The goal of this study is to rigorously characterize how the adaptive immune response contributes to the pathogenesis of cholesterol gallstones. Specifically the aims of this study are: 1. To determine which T-cell subsets contribute to cholesterol cholelithogenesis and to determine if cholelithogenesis can be prevented by immunological manipulation. To accomplish this aim T cell subsets (effector T-cells and regulatory T cells) will be transferred to Rag 2-/- mice. Furthermore, because regulatory T-cells are known to ameliorate numerous T-cell mediated diseases, their ability to prevent cholesterol gallstones will be determined utilizing transfer studies. Finally, because T- cells and lithogenic bile promote a Th1 immune response in the gallbladder the ability of mice deficient in Th1 immunity to form cholesterol gallstones will be analyzed. 2. To mechanistically understand how T-cells promote cholesterol gallstone formation. There are several mechanisms whereby T-cells may promote cholesterol gallstone formation. Since inflammation is known to alter hepatic lipid metabolism and transport I will first determine if T-cells alter the concentration of biliary lipids in hepatic or gallbladder bile. Next, because inflammation and gallbladder wall damage occur concurrently with gallstone formation and because gallbladder cytokine expression is markedly altered in mice possessing T-cells I will be determine if T-cells damage the gallbladder or alter gallbladder contractility in the presence of lithogenic bile. Finally, because nucleation is a key factor in cholesterol cholelithogenesis I will determine if T-cells alter the kinetics of gallbladder bile nucleation. The proposed studies will systematically and mechanistically determine the roll of T-cells and adaptive immunity in murine cholesterol gallstone formation. These studies will provide detailed insight into the pathogenesis of cholesterol gallstones. This murine model should provide a framework with which to explore the role of adaptive immunity and human cholesterol gallstone formation and may alter the way the disease is studied, diagnosed, prevented and treated in humans.
描述(由申请人提供):
胆固醇胆结石是一种常见的昂贵疾病,涉及遗传和环境贡献的病原体(SIC)不完全理解。通常,当胆汁用胆固醇过饱和时,这些石头形成在胆囊中。但是,过饱和的胆汁不足以产生胆固醇胆结石。促成胆固醇胆结石的环境因素在很大程度上是未知的,最近的研究表明,在人类中,独特的环境因素表明对胆石形成的贡献大于50%。最近,我们证明了自适应免疫反应对胆固醇胆结石的形成巨大贡献。我们假设自适应免疫刺激是导致人类胆固醇胆结石的环境因素之一。根据迄今为止生成的数据,这种形成的可能生物学模型是T细胞介导的对胆囊壁的损害,从而导致胆囊功能的逐渐丧失。这项研究的目的是严格表征适应性免疫反应如何有助于胆固醇胆结石的发病机理。具体而言,这项研究的目的是:1。确定哪种T细胞子集有助于胆固醇胆石裂生成,并确定是否可以通过免疫学操纵来预防胆石生成。为了实现此目标T细胞子集(效应t细胞和调节性T细胞)将转移到RAG 2 - / - 小鼠中。此外,由于已知调节性T细胞可以改善许多T细胞介导的疾病,因此使用转移研究来确定其预防胆固醇胆结石的能力。最后,由于T细胞和岩性胆汁在胆囊中促进了Th1免疫反应,因此将分析缺乏Th1免疫力形成胆固醇胆结石的小鼠的能力。 2。从机械上理解T细胞如何促进胆固醇胆结石的形成。有几种机制,T细胞可以促进胆固醇胆结石的形成。由于已知炎症会改变肝脂质代谢和运输,因此我将首先确定T细胞是否改变了肝或胆囊胆汁中胆汁脂的浓度。接下来,由于胆结石的形成同时发生炎症和胆囊壁损伤,并且由于具有T细胞的小鼠的胆囊细胞因子表达发生了明显改变,因此在存在岩性胆汁的情况下,T细胞会确定T细胞是否损坏胆囊或改变胆囊收缩力。最后,由于成核是胆固醇胆石发生的关键因素,因此我将确定T细胞是否改变了胆囊胆汁成核的动力学。拟议的研究将系统和机械地确定鼠胆固醇胆结石形成中T细胞的卷和适应性免疫。这些研究将为胆固醇胆结石的发病机理提供详细的见解。该鼠模型应提供一个框架,以探索适应性免疫和人类胆固醇胆结石的作用,并可能改变在人类中研究,诊断,预防和治疗疾病的方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirk James Maurer其他文献
Kirk James Maurer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirk James Maurer', 18)}}的其他基金
The role of T-cells and Th 1 immunity in cholesterol gallstones
T 细胞和 Th 1 免疫在胆固醇胆结石中的作用
- 批准号:
7826139 - 财政年份:2007
- 资助金额:
$ 13.53万 - 项目类别:
The role of T-cells and Th 1 immunity in cholesterol gallstones
T 细胞和 Th 1 免疫在胆固醇胆结石中的作用
- 批准号:
7499020 - 财政年份:2007
- 资助金额:
$ 13.53万 - 项目类别:
The role of T-cells and Th 1 immunity in cholesterol gallstones
T 细胞和 Th 1 免疫在胆固醇胆结石中的作用
- 批准号:
7906629 - 财政年份:2007
- 资助金额:
$ 13.53万 - 项目类别:
The role of T-cells and Th 1 immunity in cholesterol gallstones
T 细胞和 Th 1 免疫在胆固醇胆结石中的作用
- 批准号:
7653639 - 财政年份:2007
- 资助金额:
$ 13.53万 - 项目类别:
The role of T-cells and Th 1 immunity in cholesterol gallstones
T 细胞和 Th 1 免疫在胆固醇胆结石中的作用
- 批准号:
8132800 - 财政年份:2007
- 资助金额:
$ 13.53万 - 项目类别:
相似国自然基金
溃结安对异常胆液质型UC病证载体模型大鼠NEI网络功能的整体调控及其机制
- 批准号:81260564
- 批准年份:2012
- 资助金额:50.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Significance of B cells and humoral immunity in the pathogenesis of biliary atres
B细胞和体液免疫在胆道闭锁发病机制中的意义
- 批准号:
8852605 - 财政年份:2014
- 资助金额:
$ 13.53万 - 项目类别:
Significance of B cells and humoral immunity in the pathogenesis of biliary atres
B细胞和体液免疫在胆道闭锁发病机制中的意义
- 批准号:
9068664 - 财政年份:2014
- 资助金额:
$ 13.53万 - 项目类别:
Significance of B cells and humoral immunity in the pathogenesis of biliary atres
B细胞和体液免疫在胆道闭锁发病机制中的意义
- 批准号:
8729236 - 财政年份:2014
- 资助金额:
$ 13.53万 - 项目类别:
Regulation of the ABCG5 ABCG8 Sterol Transporter
ABCG5 ABCG8 甾醇转运蛋白的调节
- 批准号:
8274829 - 财政年份:2009
- 资助金额:
$ 13.53万 - 项目类别:
Regulation of the ABCG5 ABCG8 Sterol Transporter
ABCG5 ABCG8 甾醇转运蛋白的调节
- 批准号:
7881405 - 财政年份:2009
- 资助金额:
$ 13.53万 - 项目类别: